Market research
MP6N.F Merrimack Pharmaceuticals, Inc
F EUR Not available
Latest close
—
—
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 53M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 39.%
- Beta
- 2.22
Community
Investor discussion
1 comment
Sign in to join the MP6N.F discussion.
5 years, 7 months ago
Merrimack Pharmaceuticals, Inc is currently in a long term uptrend where the price is trading 4.0% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Merrimack Pharmaceuticals, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 134.0% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 76.7% to $-2M since the same quarter in the previous year.
Based on the above factors, Merrimack Pharmaceuticals, Inc gets an overall score of 2/5.